AOTXF

Apotex Health Corp. is a Canada-based global health company. The Company's three business lines comprise conventional generic pharmaceuticals (Conventional Generics); specialty generic pharmaceuticals (Specialty Generics), and Brands & Biosimilars, a business line consisting of biosimilar pharmaceuticals, branded specialty pharmaceuticals, and branded consumer health and wellness products. The Company manages its business across three geographic reportable segments: Canada, the U.S. and International, based on the location of customers. Its conventional generics include small molecule oral solid dose (OSD) (immediate or extended release). Its specialty generics include liquids, inhalers, topicals, powders, injectables, specialty oncology OSDs, and 505(b)(2) repurposed molecules. It covers various therapeutic areas, including ophthalmology, oncology, dermatology, and hematology. Its portfolio consists of over 800 products (over 300 of which are sold across multiple geographic segments).